Tratamiento de la anemia renal con administración una vez cada dos semanas de darbepoetina alfa en pacientes con insuficiencia renal crónica prediálisis previamente tratados con epoetina alfa
M. CACHO , M. MOLINA , M. A. GARCIA HERNANDEZ , M. J. NAVARRO , F. PEREZ SILVA , M. C. DE GRACIA
Leído
10564
Vecesse ha leído el artículo
2764
Total PDF
7800
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 30 | 7 | 37 |
| 2025 5 | 97 | 35 | 132 |
| 2025 4 | 96 | 31 | 127 |
| 2025 3 | 113 | 57 | 170 |
| 2025 2 | 111 | 31 | 142 |
| 2025 1 | 102 | 46 | 148 |
| 2024 12 | 52 | 18 | 70 |
| 2024 11 | 58 | 48 | 106 |
| 2024 10 | 70 | 49 | 119 |
| 2024 9 | 53 | 40 | 93 |
| 2024 8 | 73 | 65 | 138 |
| 2024 7 | 63 | 25 | 88 |
| 2024 6 | 92 | 36 | 128 |
| 2024 5 | 78 | 55 | 133 |
| 2024 4 | 60 | 26 | 86 |
| 2024 3 | 68 | 17 | 85 |
| 2024 2 | 42 | 38 | 80 |
| 2024 1 | 48 | 27 | 75 |
| 2023 12 | 60 | 30 | 90 |
| 2023 11 | 71 | 26 | 97 |
| 2023 10 | 59 | 34 | 93 |
| 2023 9 | 86 | 29 | 115 |
| 2023 8 | 64 | 21 | 85 |
| 2023 7 | 61 | 26 | 87 |
| 2023 6 | 75 | 28 | 103 |
| 2023 5 | 76 | 31 | 107 |
| 2023 4 | 54 | 22 | 76 |
| 2023 3 | 49 | 19 | 68 |
| 2023 2 | 35 | 26 | 61 |
| 2022 1 | 66 | 20 | 86 |
| 2022 12 | 53 | 31 | 84 |
| 2022 11 | 54 | 21 | 75 |
| 2022 10 | 48 | 30 | 78 |
| 2022 9 | 24 | 37 | 61 |
| 2022 8 | 60 | 34 | 94 |
| 2022 7 | 60 | 39 | 99 |
| 2022 6 | 30 | 28 | 58 |
| 2022 5 | 61 | 31 | 92 |
| 2022 4 | 53 | 38 | 91 |
| 2022 3 | 54 | 40 | 94 |
| 2022 2 | 54 | 42 | 96 |
| 2021 1 | 44 | 46 | 90 |
| 2021 12 | 49 | 35 | 84 |
| 2021 11 | 62 | 46 | 108 |
| 2021 10 | 67 | 38 | 105 |
| 2021 9 | 55 | 40 | 95 |
| 2021 8 | 68 | 51 | 119 |
| 2021 7 | 56 | 18 | 74 |
| 2021 6 | 49 | 20 | 69 |
| 2021 5 | 40 | 20 | 60 |
| 2021 4 | 128 | 61 | 189 |
| 2021 3 | 90 | 25 | 115 |
| 2021 2 | 103 | 14 | 117 |
| 2020 1 | 68 | 15 | 83 |
| 2020 12 | 47 | 4 | 51 |
| 2020 11 | 61 | 11 | 72 |
| 2020 10 | 52 | 12 | 64 |
| 2020 9 | 52 | 9 | 61 |
| 2020 8 | 60 | 6 | 66 |
| 2020 7 | 49 | 8 | 57 |
| 2020 6 | 72 | 13 | 85 |
| 2020 5 | 88 | 26 | 114 |
| 2020 4 | 82 | 13 | 95 |
| 2020 3 | 113 | 10 | 123 |
| 2020 2 | 106 | 18 | 124 |
| 2020 1 | 103 | 14 | 117 |
| 2019 12 | 70 | 22 | 92 |
| 2019 11 | 87 | 23 | 110 |
| 2019 10 | 61 | 7 | 68 |
| 2019 9 | 64 | 9 | 73 |
| 2019 8 | 55 | 21 | 76 |
| 2019 7 | 44 | 19 | 63 |
| 2019 6 | 36 | 4 | 40 |
| 2019 5 | 31 | 6 | 37 |
| 2019 4 | 75 | 16 | 91 |
| 2019 3 | 42 | 25 | 67 |
| 2019 2 | 51 | 23 | 74 |
| 2019 1 | 19 | 11 | 30 |
| 2018 12 | 57 | 26 | 83 |
| 2018 11 | 59 | 27 | 86 |
| 2018 10 | 65 | 18 | 83 |
| 2018 9 | 49 | 18 | 67 |
| 2018 8 | 47 | 14 | 61 |
| 2018 7 | 37 | 7 | 44 |
| 2018 6 | 25 | 19 | 44 |
| 2018 5 | 39 | 23 | 62 |
| 2018 4 | 32 | 12 | 44 |
| 2018 3 | 33 | 10 | 43 |
| 2018 2 | 37 | 18 | 55 |
| 2018 1 | 32 | 10 | 42 |
| 2017 12 | 36 | 12 | 48 |
| 2017 11 | 41 | 19 | 60 |
| 2017 10 | 38 | 14 | 52 |
| 2017 9 | 32 | 14 | 46 |
| 2017 8 | 42 | 30 | 72 |
| 2017 7 | 29 | 12 | 41 |
| 2017 6 | 26 | 22 | 48 |
| 2017 5 | 21 | 28 | 49 |
| 2017 4 | 23 | 18 | 41 |
| 2017 3 | 18 | 20 | 38 |
| 2017 2 | 19 | 25 | 44 |
| 2016 1 | 20 | 30 | 50 |
| 2016 12 | 34 | 21 | 55 |
| 2016 11 | 38 | 45 | 83 |
| 2016 10 | 46 | 43 | 89 |
| 2016 9 | 115 | 38 | 153 |
| 2016 8 | 156 | 38 | 194 |
| 2016 7 | 135 | 40 | 175 |
| 2016 6 | 108 | 0 | 108 |
| 2016 5 | 147 | 0 | 147 |
| 2016 4 | 97 | 0 | 97 |
| 2016 3 | 110 | 0 | 110 |
| 2016 2 | 111 | 0 | 111 |
| 2015 1 | 121 | 0 | 121 |
| 2015 12 | 95 | 0 | 95 |
| 2015 11 | 121 | 0 | 121 |
| 2015 10 | 101 | 0 | 101 |
| 2015 9 | 63 | 0 | 63 |
| 2015 8 | 111 | 0 | 111 |
| 2015 7 | 93 | 0 | 93 |
| 2015 6 | 77 | 0 | 77 |
| 2015 5 | 43 | 0 | 43 |
| 2015 4 | 9 | 0 | 9 |
Mostrar todo
